A Study to Validate the Diagnostic Accuracy of a Transportable Magnetocardiograph Device for Acute Coronary Syndrome

Overview

About this study

The purpose of this study is to validate the diagnostic accuracy of a transportable magnetocardiograph device for acute coronary syndrome (ACS), focusing on rule-out capability, in patients who present to the emergency department with chest pain symptoms consistent with ACS.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Patient presents to the Emergency Department (ED) with chest pain syndrome of suspected cardiac origin (i.e., symptoms consistent with acute cororonary syndrome (ACS)).
18+ year old male or female.
Patient is willing and able to give written informed consent .

Exclusion Criteria:

ST-segment Elevation MI (STEMI)
Clear non-ischemic cause for symptoms (e.g., trauma) .
Hemodynamic instability on admission (e.g., BP>220mmHg systolic & >110mmHg diastolic, <80mmHg systolic & <40mmHg diastolic, HR>160bpm).
Ventricular tachycardia or fibrillation that cannot be treated effectively.
Atrial fibrillation.
Thoracic metal implants.
Pacemaker or internal defibrillator.
Pregnancy (if after 20-week period)* or lactation.
Patient unable to lie down (i.e., supine position) or stay still on the examination bed.
Patient unable to understand the informed consent process and/or has a poor understanding of English (e.g., English- speaking relative/translator not available).
Patient unable to comply with the requirements of the protocol.

More information

Publications

Publications are currently not available

Clinical Trials